Paxlovid (nirmatrelvir and ritonavir) and Lagevrio (molnupiravir) are two oral treatment options for mild-to-moderate coronavirus disease 2019 (COVID-19) in people who are at high risk for severe COVID-19 disease. However, they have some key differences.Continue reading ...
Patients who recover from COVID-19 make antibodies to the virus that may impart immunity for at least 6 months; however, breakthrough infections do occur and may be more likely with newly circulating variants of the virus. Immunizing with the latest recommended COVID-19 vaccine can help to ...
How long are you contagious with COVID-19? You are contagious and may spread the virus that causes COVID-19, at least 2 days before you show symptoms and for up to 10 days from the day you have your first symptom. The highest risk of transmitting the virus to someone else in the fe...